Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nick Barton

Showing results (31-40 of 49) with videos related to

Pageof 5
Sort By:
Genes|June 22, 2017
Identifying Bird Remains Using Ancient DNA BarcodingLove Dalén, Vendela K Lagerholm, Johan A A Nylander, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 6, 2007
82,000-year-old shell beads from North Africa and implications for the origins of modern human behaviorAbdeljalil Bouzouggar, Nick Barton, Marian Vanhaeren, et al.
Journal of Medicinal Chemistry|October 12, 2016
Correction to Evolution of a Novel, Orally Bioavailable Series of PI3Kδ Inhibitors from an Inhaled Lead for the Treatment of Respiratory DiseaseAugustin Amour, Nick Barton, Anthony W J Cooper, et al.
Bioorganic & Medicinal Chemistry Letters|July 8, 2009
The identification and optimisation of novel and selective diamide neuropeptide Y Y2 receptor antagonistsGillian E Lunniss, Ashley A Barnes, Nick Barton, et al.
Journal of Medicinal Chemistry|July 19, 2016
Evolution of a Novel, Orally Bioavailable Series of PI3Kδ Inhibitors from an Inhaled Lead for the Treatment of Respiratory DiseaseAugustin Amour, Nick Barton, Anthony W J Cooper, et al.
Journal of Medicinal Chemistry|August 23, 2016
Correction to Evolution of a Novel, Orally Bioavailable Series of PI3Kδ Inhibitors from an Inhaled Lead for the Treatment of Respiratory DiseaseAugustin Amour, Nick Barton, Anthony W J Cooper, et al.
ACS Medicinal Chemistry Letters|July 18, 2020
Design and Development of a Macrocyclic Series Targeting Phosphoinositide 3-Kinase δJonathan A Spencer, Ian R Baldwin, Nick Barton, et al.
The Journal of Biological Chemistry|August 13, 2013
Discovery of novel irreversible inhibitors of interleukin (IL)-2-inducible tyrosine kinase (Itk) by targeting cysteine 442 in the ATP pocketJohn D Harling, Angela M Deakin, Sébastien Campos, et al.
Global Change Biology|October 21, 2016
Range shifts or extinction? Ancient DNA and distribution modelling reveal past and future responses to climate warming in cold-adapted birdsVendela K Lagerholm, Edson Sandoval-Castellanos, Amélie Vaniscotte, et al.
Bioorganic & Medicinal Chemistry Letters|November 16, 2010
The identification of a series of novel, soluble non-peptidic neuropeptide Y Y2 receptor antagonistsGillian E Lunniss, Ashley A Barnes, Nick Barton, et al.
Pageof 5

Showing results (31-40 of 49) with videos related to

Sort By:
Pageof 5
Genes|June 22, 2017
Identifying Bird Remains Using Ancient DNA BarcodingLove Dalén, Vendela K Lagerholm, Johan A A Nylander, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 6, 2007
82,000-year-old shell beads from North Africa and implications for the origins of modern human behaviorAbdeljalil Bouzouggar, Nick Barton, Marian Vanhaeren, et al.
Journal of Medicinal Chemistry|October 12, 2016
Correction to Evolution of a Novel, Orally Bioavailable Series of PI3Kδ Inhibitors from an Inhaled Lead for the Treatment of Respiratory DiseaseAugustin Amour, Nick Barton, Anthony W J Cooper, et al.
Bioorganic & Medicinal Chemistry Letters|July 8, 2009
The identification and optimisation of novel and selective diamide neuropeptide Y Y2 receptor antagonistsGillian E Lunniss, Ashley A Barnes, Nick Barton, et al.
Journal of Medicinal Chemistry|July 19, 2016
Evolution of a Novel, Orally Bioavailable Series of PI3Kδ Inhibitors from an Inhaled Lead for the Treatment of Respiratory DiseaseAugustin Amour, Nick Barton, Anthony W J Cooper, et al.
Journal of Medicinal Chemistry|August 23, 2016
Correction to Evolution of a Novel, Orally Bioavailable Series of PI3Kδ Inhibitors from an Inhaled Lead for the Treatment of Respiratory DiseaseAugustin Amour, Nick Barton, Anthony W J Cooper, et al.
ACS Medicinal Chemistry Letters|July 18, 2020
Design and Development of a Macrocyclic Series Targeting Phosphoinositide 3-Kinase δJonathan A Spencer, Ian R Baldwin, Nick Barton, et al.
The Journal of Biological Chemistry|August 13, 2013
Discovery of novel irreversible inhibitors of interleukin (IL)-2-inducible tyrosine kinase (Itk) by targeting cysteine 442 in the ATP pocketJohn D Harling, Angela M Deakin, Sébastien Campos, et al.
Global Change Biology|October 21, 2016
Range shifts or extinction? Ancient DNA and distribution modelling reveal past and future responses to climate warming in cold-adapted birdsVendela K Lagerholm, Edson Sandoval-Castellanos, Amélie Vaniscotte, et al.
Bioorganic & Medicinal Chemistry Letters|November 16, 2010
The identification of a series of novel, soluble non-peptidic neuropeptide Y Y2 receptor antagonistsGillian E Lunniss, Ashley A Barnes, Nick Barton, et al.
Pageof 5